Go Back


Held: October 8, 2016
7:30am – 4:25pm
Royal Sonesta Boston
40 Edwin H Land Blvd
Cambridge, MA 02142

View / Download Slides

Access Post Program Survey

Program Description:

The 2016 Botulinum Toxin Therapy Update: Focus on Limb Dysfunction is an interactive educational program with case-based presentations and workshops that provide a review of the mechanism of action, therapeutic rationale, and clinical application of botulinum neurotoxin in the management of limb dysfunction. This conference includes a live patient workshop for physicians and allied health care professionals on limb injections techniques as well as, a comprehensive review of upper and lower muscle anatomy with a cadaver lab. Participants will also have an opportunity to review ultrasound, EMG, and electrical stimulation guidance updates and the most recent billing and coding recommendations.

Target Audience:

The target audience for this live 7.5-Hour certified conference is neurologists, physiatrists, pain specialists, resident physicians, nurse practitioners, registered nurses, physician assistants, physical therapists and other allied health practitioners interested in learning more about botulinum toxin therapy.

Educational Objectives:

After completing this activity, the participant should be better able to:

  • Discuss the mechanism of action and the conceptual basis for therapeutic botulinum neurotoxin therapy in patients with limb dysfunction
  • Explain the anatomy of upper and lower limb muscles typically injected with botulinum toxin for the treatment of spasticity, dystonia, and pain.
  • Review the current literature regarding the treatment of limb spasticity and pain in adults and children with botulinum toxin therapy
  • Evaluate commercial preparations and application of botulinum neurotoxin in limb dysfunction
  • Identify appropriate patients for botulinum neurotoxin therapy and determine appropriate injection-site-specific selection and dosing strategies
  • Discuss the importance of post-injection follow-up and strategies to improve patient outcomes
  • Select the proper billing and coding for botulinum toxin injections


Morning Sessions:

7:30am – 8:00am Breakfast
8:00am – 8:15am Welcome and Introductions – Peter McAllister, MD
8:15am – 8:45am Scientific Update – Laxman Bahroo, MD
8:45am – 9:15am Limb Dystonias – Peter McAllister, MD
9:15am – 9:45am Splinting, Casting, and Physical Therapy – Caryn McAllister, PT, DPT
9:45am – 10:00am Break
10:00am – 10:30am Limb Pain (Tendonitis, Osteoarthritis, Plantar Fasciitis, Piriformis Syndrome) – Zahid H. Bajwa, MD, FAHS
10:30am – 11:00am Ultrasound, EMG, and Electrical Stimulation Guidance – Katharine E. Alter, MD
11:00am – 11:45am Limb Spasticity in Children and Adults – Peter McAllister, MD
11:45am – 12:30pm Working Lunch (Billing and Coding Update) – Martin Taylor, DO, PhD

Afternoon Sessions:

12:30pm – 1:00pm Pre-Workshop Anatomy Overview  – Sherry Downie, MD
1:10pm – 2:30pm Injections and Anatomy Cadaver Lab Session 1
Group A: Patient Limb Injections – Katharine E. Alter, MD
– Laxman Bahroo, DO
– Zahid H. Bajwa, MD, FAHS
– Zachary W. Bohart, MD
– Priscilla L. Rodriguez, LPN
Group B: Anatomy Cadaver Lab – Kathy Dooley, MSc, DC
– Sherry A. Downie, PhD
– Peter McAllister, MD
– Martin Taylor, DO, PhD
2:40pm – 4:00pm Injections and Anatomy Cadaver Lab Session 2
Group A: Anatomy Cadaver Lab – Kathy Dooley, MSc, DC
– Sherry A. Downie, PhD
– Peter McAllister, MD
– Martin Taylor, DO, PhD
Group B: Patient Limb Injections – Katharine E. Alter, MD
– Laxman Bahroo, DO
– Zahid H. Bajwa, MD, FAHS
– Zachary W. Bohart, MD
– Priscilla L. Rodriguez, LPN
4:10pm – 4:25pm Closing Remarks – Peter McAllister, MD

Course Director:

Peter McAllister, MDPeter McAllister, MD
Medical Director, New England Institute for Neurology and Headache
Chief Medical Officer, New England Institute for Clinical Research
Stamford, CT
Clinical Assistant Professor, Yale University School of Medicine
Assistant Professor, Frank H. Netter School of Medicine
Quinnipiac University


Laxman Bahroo, DOLaxman Bahroo, DO
Director Botulinum Toxin Clinic
Director Neurology Residency Program
Associate Professor of Neurology
Georgetown University Hospital
Washington, DC


Katharine E. Alter, MDKatharine E. Alter, MD
Physiatrist, Mount Washington Pediatric Hospital, Baltimore MD
Clinical Assistant Professor, PM&R
AT Still University, Mesa AZ


Zahid H. Bajwa, MD, FAHSZahid H. Bajwa, MD, FAHS
Director, Boston Headache Institute
Director, Clinical Research at Boston PainCare
Waltham, MA


Zachary W. Bohart, MDZachary W. Bohart, MD
Adult Physiatrist, Assistant Professor
Tufts University School of Medicine
Comprehensive Spasticity Management
Tufts Medical Center, Braintree and New England Rehabilitation Hospitals
Boston, MA

Kathy Dooley MSc, DCKathy Dooley MSc, DC
Adjunct instructor, Einstein College of Medicine of Yeshiva University
Adjunct instructor, New York University College of Dentistry
Teaching consultant, Weill Cornell Medical College of Cornell University
Chiropractor and co-owner, Catalyst S.P.O.R.T., LLC
Lead instructor and founder, Immaculate Dissection™ seminar series
Lead Instructor, NeuroKinetic Therapy™ (NKT) seminar series
New York, NY

>Sherry A. Downie, PhDSherry A. Downie, PhD
Professor, Clinical Anatomy and Structural Biology
Professor, Clinical Physical Medicine and Rehabilitation
Albert Einstein College of Medicine
Bronx, NY

>Caryn McAllister, PT, DPTCaryn McAllister, PT, DPT
High Quality Home Therapy, LLC
Stamford, CT



>Priscilla L. Rodriguez, LPNPriscilla L. Rodriguez, LPN
Patient Service Specialist
New England Institute for Neurology & Headache
Stamford, CT

Martin Taylor, DO, PhDMartin Taylor, DO, PhD
Neurology / OrthoNeuro
Clinical Associate Professor, Neurology
Ohio University College of Osteopathic Medicine
Columbus, OH

Registration Fee:

There is a $50 registration fee for this educational activity. A full refund will be provided for cancellations up to 14 days prior to the event.

Disclosure of Conflicts of Interest:

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager Reported Financial Relationship
Margaret Clark Nothing to disclose
Ashley Marostica, RN, MSN Nothing to disclose
Amanda Glazar, PhD Nothing to disclose
Andrea Funk Nothing to disclose

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for 7.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please contact
 Global at 303-395-1782 or inquire@globaleducationgroup.com

This activity is provided by Global Education Group.



This activity is proudly endorsed by the North American Neurotoxin Association.


Support Statement:

This activity is supported by educational grants provided by Ipsen Biopharmaceuticals, Inc., and US WorldMeds LLC.

Sponsorship and Exhibit Opportunities:


Instructions to Receive Credit:

In order to receive credit for this activity, the participant must complete the pre-assessment, post-assessment, evaluation, and then claim credit.